ABSTRACT In cultured bovine chromaffin cells, changes in the dynamic state of enkephalin stores elicited experimentally were studied by measuring cellular proenkephaliu mRNA, as well as enkephalin precursors and authentic enkephalin content of cells and culture media. In parallel, tyrosine hydroxylase mRNA and catecholamine cell content were also determined. Low concentrations (0.5-100 pM) of dexamethasone increased the cell contents of proenkephalin mRNA and enkephalin-containing peptides. High concentrations of the hormone (1 MuM) were required to increase the cell contents of tyrosine hydroxylase mRNA and catecholamines. Depolarization of the cells with 10 ,uM veratridine resulted in a depletion of enkephalin and catecholamine stores after 24 hr. The enkephalin, but not the catecholamine, content was restored by 48 hr. An increase in proenkephalin mRNA content might account for the recovery; this increase was curtailed by tetrodotoxin and enhanced by 10 pM dexamethasone. Tyrosine hydroxylase mRNA content was not significantly modified by depolarization, even in the presence of 1 MuM dexamethasone. Aldosterone, progesterone, testosterone, or estradiol (1 MuM) failed to change proenkephalin mRNA. Hence, dexamethasone appears to exert a specific permissive action on the stimulation of the proenkephalin gene elicited by depolarization. Though the catecholamines and enkephalins are localized in the same chromaffin granules and are coreleased by depolarization, the genes coding for the processes that are rate limiting in the production of these neuromodulators can be differentially regulated.
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Catecholamines and enkephalin-related peptides are colocalized in adrenal chromaffin cells (1) . These peptides reside in the same storage vesicles with epinephrine and can be released by the same stimuli (2) (3) (4) (5) , suggesting that the stores of both neuromodulators might be regulated by common mechanisms. Glucocorticoids function as a physiological stimulus of adrenal medulla and control positively the transcription of different genes by the interaction of the steroid-receptor complex with specific sites of the genome upstream from the transcription starting site or within the transcriptional unit (6) (7) (8) (9) . Since, in primary cultures of chromaffin cells, depolarizing stimuli increase the accumulation of proenkephalin (proEnk) mRNA (10) but fail to increase significantly the content of tyrosine hydroxylase (TyrOHase) (11), we wondered whether there was a differential role of the glucocorticoids in the expression of these two genes.
When chromaffin cells are cultured in hypoglucocorticoid media, low concentrations (picomolar or less) of dexamethasone significantly increase the synthesis of enkephalinrelated peptides and the content of proEnk mRNA. In contrast, TyrOHase mRNA and catecholamine content are barely increased by micromolar concentrations of the hormone. Furthermore, veratridine (10 ,uM) increases proEnk mRNA content and this increase is potentiated by 10 pM dexamethasone. Depolarization does not modify the amount of TyrOHase mRNA, either in the presence or in the absence of dexamethasone.
MATERIALS AND METHODS
Cell Culture. Chromaffin cells were prepared from fresh bovine adrenal glands as described (12) . Cells were plated in Costar 12-well clusters or 60-or 100-mm Petri dishes at a density of0.9-1.2 x l05 cells per cm2, in Dulbecco's modified Eagle's medium containing 10% dialyzed calf serum, 5 mM Hepes at pH 7.4, penicillin at 100 units/ml, streptomycin at 100 ,ug/ml, gentamycin at 50 ,g/ml, mycostatin at 50 units/ ml, and 20 ,uM cystosine arabinonucleoside. Calf serum corticosterone (0.10-0.15 ,uM) and other steroid levels were reduced by repetitive dialysis: the concentration of these hormones in the final culture medium was estimated to be in the 0.1 pM range. Two to 3 days after plating, the medium was removed and fresh medium, containing the various steroids, was added. A 1 mM working solution of dexamethasone was prepared in 20% ethanol; after dilution the highest concentration of ethanol in the medium was 4 mM, and control dishes received the equivalent concentration of ethanol, Veratridine (base) was dissolved in glacial acetic acid (5 , in each sample were carried out as described (13) . The specific activity of the proEnk cDNA probe was 100-300 cpm/pg. For the TyrOHase mRNA measurements, the blots were prehybridized and hybridized with the entire plasmid (14) , under conditions described for intact plasmid hybridization (15) . The, specific activity of the nick-translated plasmid was 200-300 cpm/pg.
Chromatographic Analysis of Opioid Peptides in Cell Extracts and Culture Medium. Cells (2.5 x 106) were homogenized in 0.8 ml of 1 M acetic acid/0.02 M HCl/0.1% 2-mercaptoethanol. After centrifugation (3080 x g for 10 min), 0.5 ml of the supernatant was applied to a Sephadex G-75 (superfine) column (0.9 x 60 cm) and eluted with 1 M acetic acid at a flow rate of 1.8 ml/hr. Fractions were collected each 20 min.
The culture medium was centrifuged (10 min at 500 x g) to remove any floating cells. Aliquots (1 ml) were mixed with 1 ml of the extraction medium and passed twice through a C18 Sep-Pak column (Waters Associates). Peptides were eluted in 3 ml of 50%6 (vol/vol) 1-propanol. After lyophilization, the samples were processed by reverse-phase HPLC, using a Bio-Sil ODS-10 column with a Bio-Sil ODS-5 S precolumn (BioRad). Elution was performed with a linear gradient of20-50% acetonitrile in 0.1% aqueous trifluoroacetic acid over 90 min at a flow rate of 0.33 ml/min. Three-minute fractions were collected. Standards added to fresh culture medium were chromatographed under identical conditions. Peptide Radioimmunoassay. Fractions from the Sephadex G-75 chromatography were lyophilized and reconstituted in 650 ,ul of 100 mM Tris-HCl, pH 7.4/50 mM NaCl. Duplicate (13, 16) . The antibody against [Met]Enk-ArgPhe recognizes synthetic peptide B (Phe-Ala-Glu-Pro-LeuSer-Glu-Glu-Glu-Gly-Glu-Ser-Tyr-Ser-Lys-Glu-Val-ProGlu -Met -Glu -Lys -Arg -Tyr -Gly -Gly -Phe -Met -Arg -Phe) (Peninsula Laboratories, San Carlos, CA) with a cross-reactivity of 50%.
Catecholamine Measurements. The epinephrine and norepinephrine were separated by HPLC and measured by electrochemical detection (12) .
RESULTS
The relative abundance of proEnk mRNA and TyrOHase mRNA in cultured chromaffin cells was analyzed by dot-blot hybridization after treatment with different steroid hormones. Exposure to dexamethasone, but not to testosterone, aldosterone, progesterone, or estradiol (results not shown) resulted in an increase in proEnk mRNA. The glucocorticoid effect was maximal after 3 days of exposure to 10 pM dexamethasone (Table 1 ). In cells cultured for 24 ht in the presence of 1 ,uM dexamethasone, the increase in proEnk mRNA was statistically significant, whereas TyrOHase mRNA increased significantly only after 5 days of exposure to the highest concentration of dexamethasone tested (1 ,uM) ( Table 2) .
Exposure to 10 ,uM veratridine for 24 hr resulted in a 2-fold increase in the content of proEnk mRNA in the cells under hypoglucocorticoid conditions, but the same concentration of veratridine increased this specific messenger by 11-fold in the presence of 10 pM dexamethasone (Table 3 ). The increase induced by veratridine was tetrodotoxin sensitive (1 ,M); this alkaloid given alone failed to change the proEnk mRNA content ( Table 3 ). Veratridine treatment (24 hr) failed to modify TyrOHase mRNA content either in the absence or in the presence of 10 pM or 1 ,tM dexamethasone (results not shown).
To determine whether the changes in TyrOHase and proEnk mRNA content occurring as a result of dexamethasone treatment were associated with increases in the content of their products, both catecholamines and enkephalins were measured. Analysis of cell catecholamine content demonstrated that epinephrine was slightly increased (33.5%) after 3 days, while norepinephrine increased (27.5%) after noreactivity content of all peaks (Fig. 1A) , with the largest increase apparent in the 3-to 6-kDa region.
[Met]Enk-Arg-Phe immunoreactivity in both cell extracts and medium was characterized by using an (Fig. 1B) .
[Met]Enk-Arg-Phe immunoreactivity in the medium was characterized by HPLC analysis (Fig. 2) . Three peaks were observed. The first two were identified as [Met]Enk-Arg-Phe (fractions [12] [13] [14] and peptide B (fractions [16] [17] [18] [19] [20] [21] [22] [23] [24] (Fig. 2) ; the ratio of [Met]Enk-Arg-Phe to peptide 13 content remained constant for both the cells and the medium. Furthermore, dexamethasone failed to stimulate secretion: the content of [Met]Enk-Arg-Phe plus peptide B in the medium as a percentage of that in the cell remained constant (1-day control, 8.8%; 1-day dexamethasone, 6.4%; 3-day control, 15.4%; 3-day dexamethasone, 11.8%).
Depolarization of the cells with 10 ,uM veratridine resulted in a depletion of cellular catecholamines and [Met]Enk-Arg-Phe (24-55%) 24 hr later (Fig. 3) . However, by 48 hr the depletion of [Met]Enk-Arg-Phe was no longer evident (Fig. 3A) . In contrast, the catecholamine content remained low and independent of the presence or absence of dexamethasone (Fig. 3B) . dependent manner the content of proEnk mRNA as well as of enkephalin-containing peptides. Higher concentrations (10-10 to 10-6 M) failed to increase proEnk mRNA further, in agreement with a recent report showing that chromaffin cells contain high-affinity but low-capacity binding sites for glucocorticoids (17) . Experiments performed with nondialyzed calf serum failed to show any significant increase in proEnk mRNA content with the lowest concentrations of dexamethasone, but an increase was detected occasionally when higher concentrations of the hormone were used. This reduction in the intensity of the response in the presence of endogenous steroids may account for the negative results reported in vivo after dexamethasone treatment (18) . The 2.2-fold increase in proEnk mRNA content within 24 hr after dexamethasone administration clearly distinguishes the responsiveness of this system from that of the catecholamine biosynthetic pathway, since a small but significant (50%) increase of TyrOHase mRNA occurred only after 5 days exposure to the hormone.
In contrast, when the chromaffin cell content of cAMP was raised by the addition of 8-Br-cAMP or forskolin, the proEnk mRNA content (13, 19, 20) and the activity of TyrOHase (21, 22) were increased. Moreover, the time course and extent of the increase of both proEnk and TyrOHase mRNA content elicited by 8-Br-cAMP were parallel (unpublished results). Comparable stimulations of TyrOHase mRNA content are observed in PC-12 cells after exposure to agents that elevate cAMP or to dexamethasone (14) , but the time courses of the responses are very different. Taken together, these results strongly suggest that different molecular mechanisms participate in the action of dexamethasone on the dynamic state of enkephalin and catecholamine stores and further suggest that the two transmitter synthetic pathways are differentially regulated in the adrenal, despite the colocalization of the transmitters in the chromaffin cell granules.
Whether the increases in proEnk mRNA and TyrOHase mRNA elicited by dexamethasone are due to increased gene transcription or to mRNA stabilization remains to be established. Glucocorticoids have been shown to stimulate gene transcription in other systems (6-9, 23) but there is also evidence for effects on mRNA stabilization (9) . While the time course for the increase of proEnk mRNA elicited by dexamethasone is comparable to that elicited by 8-Br-cAMP, which acts transcriptionally (unpublished results), the slow time course for the increase in TyrOHase mnRNA in the case of dexamethasone and the higher concentrations required may suggest that it either acts indirectly on transcription or that in an unknown manner it stabilizes TyrOHase mRNA.
Depolarization of chromaffin cells with nicotine results in an increase in the content of proEnk mRNA and enkephalin immunoreactivity, which is, at least partially, mediated through a rise in cAMP (10) . This increase follows an initial depletion of the peptides, which supports a model of stimulus-secretion-synthesis coupling (10). Our results clearly distinguish the regulation of the proEnk gene from that of the TyrOHase gene. The dexamethasone-steroid receptor complex may play a decisive role at the level of mRNA synthesis, by "opening" the proEnk gene, which once opened is more readily transcribed (11-fold increase) after the veratridine-induced depolarization signal reaches the nucleus. Residual amounts of endogenous steroids, in our conditions, might explain the small but significant (2-fold) increase of proEnk mRNA induced by veratridine in the absence of dexamethasone.
Following the rise in proEnk mRNA, the total enkephalin immunoreactivity stored in the chromaffin cells increased after dexamethasone. A glucocorticoid effect on enkephalin peptides was reported earlier in NG-108 cells (24) , and a recent report confirms that this effect is due to an increase of proEnk mRNA (25) . This has also been shown in chromaffin (26) . Wilson and Kirshner (27) , however, failed to observe any significant effect of dexamethasone on either enkephalins or enkephalin-containing peptides in chromaffin cells cultured in serum-free defined medium. Similar disparities with these previous studies (26, 27 ) also exist in the dexamethasome effect on catecholamine content. In both cases, different culture conditions might account for these discrepancies.
In chromaffin cells as well as in intact bovine adrenal medulla, enkephalin peptides appear mainly as large polypeptides that contain enkephalin sequences flanked by pairs of basic amino acid residues (28) (29) (30) . These peptides correspond to different stages in the post-translational processing of the common precursor proEnk. Dexamethasone treatment results in an increase of all of the different molecular weight enkephalin-containing peptides, supporting the view that this hormone changes the dynamic state of the entire enkephalin pathway by activating gene transcription; the increased mRNA is in turn translated to proEnk, which is processed to the various enkephalin-containing peptides. Pulse-chase experiments would be required to determine whether dexamethasone has a specific effect on proEnk processing.
In conclusion, we have shown that glucocorticoids stimulate the expression of the proEnk gene in chromaffin cells and exert a permissive role in the proEnk mRNA stimulation elicited by veratridine depolarization. In contrast, the TyrOHase gene is not responsive to veratridine either in the absence or in the presence of glucocorticoids.
